Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole J Moreland

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
The Lancet. Infectious Diseases|November 30, 2019
Against the trend: a decrease in scarlet fever in New ZealandNicole J Moreland, Rachel H Webb
Pediatric Cardiology|January 21, 2014
Can soluble adhesion molecules accurately predict carditis in acute rheumatic fever?Nicole J Moreland, Nigel J Wilson
Immunologic Research|January 23, 2023
Human antibody profiling technologies for autoimmune diseaseLauren H Carlton, Reuben McGregor, Nicole J Moreland
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2016
Invasive Group A Streptococcal Infections in Indigenous New Zealanders With Type 2 DiabetesDeborah A Williamson, Nicole J Moreland, Susan Jack
The American Journal of Tropical Medicine and Hygiene|April 30, 2024
Reduction in Acute Post-Streptococcal Glomerulonephritis Incidence in Counties Manukau, New Zealand, after the COVID-19 PandemicAmanda Taylor, Jocelyn Neutze, Nicole J Moreland, et al.
Expert Review of Vaccines|November 13, 2015
Development of Group A streptococcal vaccines: an unmet global health needMeru Sheel, Nicole J Moreland, John D Fraser, et al.
Protein Expression and Purification|November 22, 2011
Expression and immunoaffinity purification of recombinant dengue virus 2 NS1 protein as a cleavable SUMOstar fusionKathryn Rozen-Gagnon, Nicole J Moreland, Christiane Ruedl, et al.
The Journal of Biological Chemistry|April 25, 2008
Crystal structures of F420-dependent glucose-6-phosphate dehydrogenase FGD1 involved in the activation of the anti-tuberculosis drug candidate PA-824 reveal the basis of coenzyme and substrate bindingGhader Bashiri, Christopher J Squire, Nicole J Moreland, et al.
Protein Expression and Purification|March 23, 2007
Expression, purification and crystallization of native and selenomethionine labeled Mycobacterium tuberculosis FGD1 (Rv0407) using a Mycobacterium smegmatis expression systemGhader Bashiri, Christopher J Squire, Edward N Baker, et al.
Journal of Microbiological Methods|January 25, 2017
Development of a high-throughput opsonophagocytic assay for the determination of functional antibody activity against Streptococcus pyogenes using bioluminescenceNatalie Lorenz, Jacelyn M S Loh, Nicole J Moreland, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
The Lancet. Infectious Diseases|November 30, 2019
Against the trend: a decrease in scarlet fever in New ZealandNicole J Moreland, Rachel H Webb
Pediatric Cardiology|January 21, 2014
Can soluble adhesion molecules accurately predict carditis in acute rheumatic fever?Nicole J Moreland, Nigel J Wilson
Immunologic Research|January 23, 2023
Human antibody profiling technologies for autoimmune diseaseLauren H Carlton, Reuben McGregor, Nicole J Moreland
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2016
Invasive Group A Streptococcal Infections in Indigenous New Zealanders With Type 2 DiabetesDeborah A Williamson, Nicole J Moreland, Susan Jack
The American Journal of Tropical Medicine and Hygiene|April 30, 2024
Reduction in Acute Post-Streptococcal Glomerulonephritis Incidence in Counties Manukau, New Zealand, after the COVID-19 PandemicAmanda Taylor, Jocelyn Neutze, Nicole J Moreland, et al.
Expert Review of Vaccines|November 13, 2015
Development of Group A streptococcal vaccines: an unmet global health needMeru Sheel, Nicole J Moreland, John D Fraser, et al.
Protein Expression and Purification|November 22, 2011
Expression and immunoaffinity purification of recombinant dengue virus 2 NS1 protein as a cleavable SUMOstar fusionKathryn Rozen-Gagnon, Nicole J Moreland, Christiane Ruedl, et al.
The Journal of Biological Chemistry|April 25, 2008
Crystal structures of F420-dependent glucose-6-phosphate dehydrogenase FGD1 involved in the activation of the anti-tuberculosis drug candidate PA-824 reveal the basis of coenzyme and substrate bindingGhader Bashiri, Christopher J Squire, Nicole J Moreland, et al.
Protein Expression and Purification|March 23, 2007
Expression, purification and crystallization of native and selenomethionine labeled Mycobacterium tuberculosis FGD1 (Rv0407) using a Mycobacterium smegmatis expression systemGhader Bashiri, Christopher J Squire, Edward N Baker, et al.
Journal of Microbiological Methods|January 25, 2017
Development of a high-throughput opsonophagocytic assay for the determination of functional antibody activity against Streptococcus pyogenes using bioluminescenceNatalie Lorenz, Jacelyn M S Loh, Nicole J Moreland, et al.
Pageof 11